Basic information Safety Supplier Related

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate

Basic information Safety Supplier Related

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate Basic information

Product Name:
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate
Synonyms:
  • 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate
  • 3-[(AMinoiMinoMethyl)aMino]-4-Methylbenzoic acid ethyl ester Mon
  • Ethyl 3-guanidino-4-methylbenzoate nitrate
  • Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate
  • 3-[(Aminoimethyl)amino]-4-methylbenzoic acid ethyl estermononitrate
  • ((aminoiminomethyl)amino)-4-methylbenzoic acid ethyl ester mononitrate
  • ethyl 3-guanidino-4-methylbenzoate
  • 3-(hydrazinylmethylideneamino)-4-methylbenzoic acid ethyl ester
CAS:
641569-96-2
MF:
C11H16N4O5
MW:
284.27
Mol File:
641569-96-2.mol
More
Less

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate Chemical Properties

Melting point:
197.0 to 201.0 °C
storage temp. 
Sealed in dry,Room Temperature
form 
powder to crystal
color 
White to Almost white
More
Less

Safety Information

HS Code 
2925.29.9000
More
Less

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate Usage And Synthesis

Chemical Properties

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate Appearance white to almost white powder to crystals, melting point 199 °C, storage 2-8 °C.

Uses

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate is an organic synthetic material or pharmaceutical intermediate compound that can be used in the preparation of N-phenyl-2-pyrimidinamine derivatives and in the synthesis of nilotinib and its salts. Nilotinib is a tyrosine kinase inhibitor used for the treatment of drug-resistant chronic myelogenous leukemia (CML), and in particular, for the treatment of chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukemia (CML) in adult patients whose disease has progressed on or who cannot tolerate other therapies that included imatinib. Nilotinib is administrated as a hydrochloride salt in the form of capsules that are marketed in the USA and the EU under the name Tasigna?.

3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrateSupplier

Shandong Xuanshuo Pharmaceutical Technology Co. LTD Gold
Tel
15269103900
Email
suchangzhou@shiningpharm.com
Chongqing Bioland Pharmaceuticat Ltd. Gold
Tel
023-68509220
Email
sales1@biolandpharm.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn